Literature DB >> 1742580

Floating thrombi: diagnosis and follow-up by duplex ultrasound.

D Voet1, M Afschrift.   

Abstract

The clinical features and evolution of floating thrombi (FT) diagnosed by duplex ultrasound were examined. In 76 consecutively diagnosed above-knee deep venous thromboses the prevalence of FT was 18%. Of 44 FT diagnosed in 39 patients, 18 (39%) were located in the common femoral, 12 (26%) in the popliteal and seven (15%) in the external iliac veins. Serial duplex examinations revealed that 31% of FT in the iliofemoral segment disappeared 33% remained unchanged and 36% adhered to the vein wall within 2 weeks following diagnosis. After 3 months, 87% of the floating segments had disappeared, irrespective of the localization or therapeutic regimen. Thirteen patients experienced pulmonary embolism before (12/13) or following (4/13) diagnosis of floating thrombosis; three of four superficial femoral vein FT embolized. Fifteen per cent of the patients with FT died during the study period and 28% of the thrombi were associated with a malignant neoplasm; the incidence of malignancy was 60% in superficial and 39% in common femoral vein FT.

Entities:  

Mesh:

Year:  1991        PMID: 1742580     DOI: 10.1259/0007-1285-64-767-1010

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

Review 1.  Inferior vena cava filters: current best practices.

Authors:  Anita Rajasekhar
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

2.  Multimodality imaging of the peripheral venous system.

Authors:  Diana Gaitini
Journal:  Int J Biomed Imaging       Date:  2007

3. 

Authors:  Matheus Bertanha; Rafael Elias Farres Pimenta; Gustavo Muçouçah Sampaio Brandão; Marcone Lima Sobreira; Regina Moura; Rodrigo Gibin Jaldin; Paula Angeleli Bueno de Camargo; Winston Bonetti Yoshida
Journal:  J Vasc Bras       Date:  2017 Oct-Dec

4.  Endovascular therapy for floating thrombus in the inferior vena cava.

Authors:  Zhi-Wen Zhang; Xue-Ming Chen; Ren-Ming Zhu; Chen-Yu Li; Hong-Zhi Yu; Zhong-Tao Zhang
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.